future glp-1 drugs GLP-1s like Ozempic are among the most important drug breakthroughs ever Rapid Growth of the GLP-1
Description
doi: 10.1530/JOE-11-0094
Standards of Medical Care in Diabetes2024
GLP-1 agonists and blood pressure: A review of the evidence
Figure 4 shows the cumulative incidence curves for major adverse cardiovascular events, with a lower cumulative incidence for the GLP-1 receptor agonist-SGLT-2 inhibitor combination and the curves diverging after three months of use
Exendin-4 improves Irs2 function by enhancing CREB phosphorylation in vitro and in vivo [546]
